RecruitingNot ApplicableNCT05848622

Gait Rehabilitation to Treat FastOA


Sponsor

University of North Carolina, Chapel Hill

Enrollment

70 participants

Start Date

Jun 13, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to determine the effects of real-time gait biofeedback delivered over a 6-week period on early markers of FastOA and conduct 6-week and 6-month follow-up assessments in anterior cruciate ligament reconstructed patients.


Eligibility

Min Age: 16 YearsMax Age: 35 Years

Inclusion Criteria4

  • Have completed all other formal physical therapy
  • Are between the ages of 16 and 35
  • Underwent an anterior cruciate ligament reconstruction (ACLR) between 6 and 60 months prior to enrollment
  • Demonstrate underloading during gait (vGRF- impact peak <1.12 x BW)

Exclusion Criteria4

  • A multiple ligament surgery (i.e., PCL)
  • A lower extremity fracture (i.e., displaced tibial plateau fracture)
  • Knee osteoarthritis
  • The participant has a BMI ≥ 36.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALReal-time gait biofeedback

The RTGBF interventions will include eighteen step gait training sessions. The intervention will gradually increase to 3,000 steps at the 5th session with 100% feedback. During the remaining sessions, the intervention will include 3,000 steps, but the feedback will be gradually tapered off starting with the 11th session.

BEHAVIORALSham real-time gait biofeedback

The Sham RTGBF interventions will include eighteen step gait training sessions. The intervention will gradually increase to 3,000 steps at the 5th session with 100% feedback. During the remaining sessions, the intervention will include 3,000 steps, but the feedback will be gradually tapered off starting with the 11th session.


Locations(1)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05848622


Related Trials